OREANDA-NEWS. June 21, 2010. "Grindeks" informs that the first five months of this year have been successful and the company's sales plan of medicines and active pharmaceutical ingredients has been met.

"Grindeks" Chairman of the Board Janis Romanovskis: "Thanks to the marketing and sales activities in all the important markets for "Grindeks", the strengthened strategy focused on the introduction and promotion of generics, we look optimistically to the future - this year we will achieve both the profit and turnover plan, thus earning 10 million lats."

Already a significant turnover growth is achieved in many important markets. Especially good results are in Moldova (+66%), Ukraine (+30%), Latvia (+29%) and Kazakhstan (+18%).